Viewing Study NCT06707532

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 9:39 PM
Ignite Modification Date: 2026-02-23 @ 3:01 PM
Study NCT ID: NCT06707532
Status: RECRUITING
Last Update Posted: 2024-11-27
First Post: 2024-11-24
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: The Potential Protective Effect of Using Muscle Relaxants During Electroporation Ablation (PFA)
Sponsor: 4th Military Clinical Hospital with Polyclinic, Poland
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Kidney Failure, Acute View
None Myopathy; Drugs View
None Heart Arrhythmia View
None Succinylcholine Sensitivity View
None Muscle Relaxation View
None General Anesthetic Drug Adverse Reaction View
None Projection View
Keywords:

Keywords

Keyword Brief Keyword Text View
None electroporation ablation (PFA) View
None muscle relaxants View
None rocuronium View
None chronic pain View
None acute kidney failure View
None chronic heart failure View
None drug protection View